Drug intelligence / Profile preview

xiaoshuan enteric-coated capsule

Development stage
Unknown
Lead developer
Sanmenxia Sinoway Pharmaceutical
Administration
Oral
01

Overview

Xiaoshuan Enteric-Coated Capsule is a traditional Chinese medicine (TCM) formulation primarily developed and manufactured by Shaanxi Buchang Pharmaceuticals. It is indicated for the treatment of cardiovascular and cerebrovascular diseases, including the sequelae of ischemic stroke (such as hemiplegia and numbness) and coronary heart disease. The formulation is composed of several herbal ingredients, including *Astragalus membranaceus*, *Angelica sinensis*, *Pheretima* (earthworm), and *Carthamus tinctorius*, which work synergistically to promote blood circulation, resolve blood stasis, and improve microcirculation. The enteric-coated capsule design ensures that the medication is released in the intestines, reducing potential gastric irritation and enhancing the absorption of active constituents like lumbricokinase. It is currently being investigated for its efficacy in treating post-cardio/cerebrovascular fatigue syndrome.

Brand names
Buchang Xiaoshuan
Other names
消栓肠溶胶囊Xiaoshuan Changrong Jiaonang
02

Targets

Fibrin (Factor Ia)

Beyond the preview

Go deeper on xiaoshuan enteric-coated capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoshuan enteric-coated capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call